Cargando…
Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study
Objective: Cocaine Use Disorder (CUD) has been associated with multiple complications and premature death. The purpose of the present study was to analyze the relationship between baseline medical comorbidity and long-term medical outcomes (i.e., hospitalization, death) in a cohort of patients prima...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930813/ https://www.ncbi.nlm.nih.gov/pubmed/33679404 http://dx.doi.org/10.3389/fphar.2021.625610 |
_version_ | 1783660160487522304 |
---|---|
author | Sanvisens, Arantza Hernández-Rubio, Anna Zuluaga, Paola Fuster, Daniel Papaseit, Esther Galan, Sara Farré, Magí Muga, Robert |
author_facet | Sanvisens, Arantza Hernández-Rubio, Anna Zuluaga, Paola Fuster, Daniel Papaseit, Esther Galan, Sara Farré, Magí Muga, Robert |
author_sort | Sanvisens, Arantza |
collection | PubMed |
description | Objective: Cocaine Use Disorder (CUD) has been associated with multiple complications and premature death. The purpose of the present study was to analyze the relationship between baseline medical comorbidity and long-term medical outcomes (i.e., hospitalization, death) in a cohort of patients primarily admitted for detoxification. In addition, we aimed to analyze cause-specific mortality. Methods: longitudinal study in CUD patients admitted for detoxification between 2001 and 2018. Substance use characteristics, laboratory parameters and medical comorbidity by VACS Index were assessed at admission. Follow-up and health-related outcomes were ascertained through visits and e-health records. Kaplan-Meier and Cox regression models were used to analyze survival and predictors of hospitalization and death. Results: 175 patients (77.7% men) were included. Age at admission was 35 years [IQR: 30–41 years], 59.4% of the patients being intranasal users, 33.5% injectors, and 7.1% smokers. Almost 23% of patients had concomitant alcohol use disorder, 39% were cannabis users and 9% opiate users. The median VACS Index score on admission was 10 points [IQR: 0–22]. After 12 years [IQR: 8.6–15 years] of follow-up there were 1,292 (80.7%) ED admissions and 308 (19.3%) hospitalizations. The incidence rate of ED admission and hospitalization was 18.6 × 100 p-y (95% CI: 15.8–21.8 × 100 p-y). Mortality rate was 1.4 × 100 p-y (95% CI: 0.9–2.0 × 100 p-y) and, baseline comorbidity predicted hospitalization and mortality: those with VACS Index >40 were 3.5 times (HR:3.52, 95% CI: 1.19–10.4) more likely to dye with respect to patients with VACS < 20. Conclusion: addiction care warrants optimal stratification of medical comorbidity to improve health outcomes and survival of CUD patients seeking treatment of the disorder. |
format | Online Article Text |
id | pubmed-7930813 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79308132021-03-05 Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study Sanvisens, Arantza Hernández-Rubio, Anna Zuluaga, Paola Fuster, Daniel Papaseit, Esther Galan, Sara Farré, Magí Muga, Robert Front Pharmacol Pharmacology Objective: Cocaine Use Disorder (CUD) has been associated with multiple complications and premature death. The purpose of the present study was to analyze the relationship between baseline medical comorbidity and long-term medical outcomes (i.e., hospitalization, death) in a cohort of patients primarily admitted for detoxification. In addition, we aimed to analyze cause-specific mortality. Methods: longitudinal study in CUD patients admitted for detoxification between 2001 and 2018. Substance use characteristics, laboratory parameters and medical comorbidity by VACS Index were assessed at admission. Follow-up and health-related outcomes were ascertained through visits and e-health records. Kaplan-Meier and Cox regression models were used to analyze survival and predictors of hospitalization and death. Results: 175 patients (77.7% men) were included. Age at admission was 35 years [IQR: 30–41 years], 59.4% of the patients being intranasal users, 33.5% injectors, and 7.1% smokers. Almost 23% of patients had concomitant alcohol use disorder, 39% were cannabis users and 9% opiate users. The median VACS Index score on admission was 10 points [IQR: 0–22]. After 12 years [IQR: 8.6–15 years] of follow-up there were 1,292 (80.7%) ED admissions and 308 (19.3%) hospitalizations. The incidence rate of ED admission and hospitalization was 18.6 × 100 p-y (95% CI: 15.8–21.8 × 100 p-y). Mortality rate was 1.4 × 100 p-y (95% CI: 0.9–2.0 × 100 p-y) and, baseline comorbidity predicted hospitalization and mortality: those with VACS Index >40 were 3.5 times (HR:3.52, 95% CI: 1.19–10.4) more likely to dye with respect to patients with VACS < 20. Conclusion: addiction care warrants optimal stratification of medical comorbidity to improve health outcomes and survival of CUD patients seeking treatment of the disorder. Frontiers Media S.A. 2021-02-18 /pmc/articles/PMC7930813/ /pubmed/33679404 http://dx.doi.org/10.3389/fphar.2021.625610 Text en Copyright © 2021 Sanvisens, Hernández-Rubio, Zuluaga, Fuster, Papaseit, Galan, Farré and Muga. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Sanvisens, Arantza Hernández-Rubio, Anna Zuluaga, Paola Fuster, Daniel Papaseit, Esther Galan, Sara Farré, Magí Muga, Robert Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study |
title | Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study |
title_full | Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study |
title_fullStr | Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study |
title_full_unstemmed | Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study |
title_short | Long-Term Outcomes of Patients With Cocaine Use Disorder: A 18-years Addiction Cohort Study |
title_sort | long-term outcomes of patients with cocaine use disorder: a 18-years addiction cohort study |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930813/ https://www.ncbi.nlm.nih.gov/pubmed/33679404 http://dx.doi.org/10.3389/fphar.2021.625610 |
work_keys_str_mv | AT sanvisensarantza longtermoutcomesofpatientswithcocaineusedisordera18yearsaddictioncohortstudy AT hernandezrubioanna longtermoutcomesofpatientswithcocaineusedisordera18yearsaddictioncohortstudy AT zuluagapaola longtermoutcomesofpatientswithcocaineusedisordera18yearsaddictioncohortstudy AT fusterdaniel longtermoutcomesofpatientswithcocaineusedisordera18yearsaddictioncohortstudy AT papaseitesther longtermoutcomesofpatientswithcocaineusedisordera18yearsaddictioncohortstudy AT galansara longtermoutcomesofpatientswithcocaineusedisordera18yearsaddictioncohortstudy AT farremagi longtermoutcomesofpatientswithcocaineusedisordera18yearsaddictioncohortstudy AT mugarobert longtermoutcomesofpatientswithcocaineusedisordera18yearsaddictioncohortstudy |